Evidence map›Paper›PMID 32539986›Full record

ArticleThe Lancet. Infectious diseases2020

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.

Ivan Fan-Ngai Hung, Vincent Chi-Chung Cheng, Xin Li, Anthony Raymond Tam, Derek Ling-Lung Hung, Kelvin Hei-Yeung Chiu, Cyril Chik-Yan Yip, Jian-Piao Cai, Deborah Tip-Yin Ho, Shuk-Ching Wong and 22 more

Open access · bronzeAbstract read
In one paragraph

Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 6 pooled it
21.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 6 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Pooled it
  4. Systematic Review on Outbreaks of SARS-CoV-2 on Cruise, Navy and Cargo Ships.International journal of environmental research and public health · 2021
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Real-time spatiotemporal tracking of infectious outbreaks in confined environments with a host-pathogen agent-based system.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. COVID-19 outbreaks on ships: Analysis of three representative cases.Public health in practice (Oxford, England) · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy.International journal of environmental research and public health · 2022
    Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors at 3 institutions in 2 countries.

Ivan Fan-Ngai HungInfectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Vincent Chi-Chung ChengDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Xin LiDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Anthony Raymond TamInfectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China.
Derek Ling-Lung HungDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Kelvin Hei-Yeung ChiuDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Cyril Chik-Yan YipDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Jian-Piao CaiState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Deborah Tip-Yin HoState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Shuk-Ching WongDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Sally Sau-Man LeungDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Man-Yee ChuDepartment of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
Milky Oi-Yan TangInfectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China.
Jonathan Hon-Kwan ChenDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Rosana Wing-Shan PoonDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Agnes Yim-Fong FungState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Ricky Ruiqi ZhangInfectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China; State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Erica Yuen-Wing YanState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Lin-Lei ChenState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Charlotte Yee-Ki ChoiState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Kit-Hang LeungDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Tom Wai-Hin ChungDepartment of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Sonia Hiu-Yin LamDepartment of Radiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Tina Poy-Wing LamDepartment of Radiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Jasper Fuk-Woo ChanState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Kwok-Hung ChanState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China.
Tak-Chiu WuDepartment of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
Pak-Leung HoState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Johnny Wai-Man ChanDepartment of Medicine, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
Chak-Sing LauInfectious Disease Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, China.
Kelvin Kai-Wang ToState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Kwok-Yung YuenState Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: kyyuen@hku.hk.
University of Hong Kong · HKQueen Mary Hospital · CNQueen Elizabeth Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA cruise ship is a closed-off environment that simulates the basic functioning of a city in terms of living conditions and interpersonal interactions. Thus, the Diamond Princess cruise ship, which was quarantined because of an onboard outbreak of COVID-19 in February, 2020, provides an opportunity to define the shedding pattern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient antibody responses before and after the onset of symptoms.

methodsWe recruited adult (≥18 years) passengers from Hong Kong who had been on board the Diamond Princess cruise ship docked in Yokohama, Japan in February, 2020. All participants had been found to be negative for SARS-CoV-2 by RT-PCR 4 days before disembarking and were transferred to further quarantine in a public estate in Hong Kong, where they were recruited. Participants were prospectively screened by quantitative RT-PCR (RT-qPCR) of nasopharyngeal and throat swabs, and serum IgG and IgM against internal nucleoprotein and the surface spike receptor-binding protein (RBD) of SARS-CoV-2 at baseline (upon entering quarantine) and on days 4, 8, and 12 of quarantine.

findingsOn Feb 22, 2020, 215 adults were recruited, of whom nine (4%; 95% CI 2-8) were positive for SARS-CoV-2 by RT-qPCR or serology and were hospitalised. Of these nine patients, nasopharyngeal swab RT-qPCR was positive in eight patients (89%; 57-99) at baseline. All nine patients were positive for anti-RBD IgG by day 8. Eight (89%; 57-99) were simultaneously positive for nasopharyngeal swab RT-PCR and anti-RBD IgG. One patient who was positive for anti-RBD IgG and had a negative viral load had multifocal peripheral ground-glass changes on high-resolution CT that were typical of COVID-19. Five patients (56%; 27-81) with ground-glass changes on high-resolution CT were found to have higher anti-nucleoprotein-IgG OD values on day 8 and 12 and anti-RBD IgG OD value on day 12 than patients without ground-glass changes. Six (67%; 35-88) patients remained asymptomatic throughout the 14-day quarantine period.

interpretationPatients with COVID-19 can develop asymptomatic lung infection with viral shedding and those with evidence of pneumonia on imaging tend to have an increased antibody response. Positive IgG or IgM confirmed infection of COVID-19 in both symptomatic and asymptomatic patients. A combination of RT-PCR and serology should be implemented for case finding and contact tracing to facilitate early diagnosis, prompt isolation, and treatment.

fundingShaw Foundation Hong Kong; Sanming-Project of Medicine (Shenzhen); High Level-Hospital Program (Guangdong Health Commission).

Indexed as

Disease OutbreaksSeroconversionVirus SheddingAdultAgedBetacoronavirusContact TracingCoronavirus InfectionsCOVID-19FemaleHong KongHumansJapanMaleMiddle AgedPandemics

Identifiers

PMID32539986
PMCPMC7292581
OpenAlexW3034736760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.